Loading...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen 04/27/2024 09:00 AM EDTStudy highlights need for defined markers of mpox immunity to inform public health use.
|
Loading...
Loading...